Jazz Pharmaceuticals Inc. (JAZZ). The company said it would buy privately held Azur Pharma Ltd in stock and form a specialty pharmaceutical company in Ireland. Jazz shareholders would own about 80 percent of the combined company, while Azur Pharma shareholders would own slightly over 20 percent. Jazz said the combined company, Jazz Pharmaceuticals plc, is expected to have revenue of over $475 million and generate cash of more than $200 million in the first year.
JAZZ is up 2.55 to a new high of 46.29
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment